Easy access to a self-assembled glycolipid derived from bhilawanol: a promising anti-cancer drug†
Abstract
In this study, we synthesised a series of self-assembling glycoconjugates derived from bhilawanol under environmentally friendly conditions in good yields. These self-assembling glycoconjugates displayed anti-cancer activity toward HeLa cells at an IC50 value of 125 μM with minimal side effects, holding immense potential in cancer therapeutics.